RHOA mutation in follicular T‐cell lymphoma: Clinicopathological analysis of 16 cases

Follicular T‐cell lymphoma (FTCL) is considered to originate from follicular helper T‐cell (Tfh) cells. Angioimmunoblastic T‐cell lymphoma (AITL) and peripheral T‐cell lymphomas with the Tfh phenotype, derived from Tfh cells, often harbor RHOA G17V mutation. We investigated whether RHOA mutations affect the clinicopathological features of FTCL. We performed deep sequencing and Sanger sequencing for RHOA exon 2 in 16 cases of FTCL. Nine cases showed RHOA mutations, including eight with c.G50T, p.Gly17Val and one with c.G50A, p.Gly17Glu, c.A52G, p.Lys18Glu, c.T102C, p.Tyr34Tyr and c.G145T, p.Asp49Tyr. Compared to the RHOA mutation‐negative group, the RHOA mutation‐positive group had a higher tendency for B‐immunoblasts (P = 0.06), the AITL component (P = 0.09), and higher positive rate for CD10 (P = 0.09) and BCL6 (P = 0.09), and a significantly higher positive rate for CXCL13 (P = 0.04). Although not statistically significant, the RHOA mutation‐positive group showed higher values for almost all characteristic AITL features. There was no significant difference in overall survival between RHOA mutation‐positive and ‐negative groups. The RHOA mutation may play an important role in clinicopathological characteristics and lymphomagenesis of FTCL. A more detailed investigation is needed to highlight the importance of RHOA mutations in FTCL.

[1]  J. Aster,et al.  RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. , 2018, Blood.

[2]  M. Seto,et al.  Clinicopathological analysis of polyploid diffuse large B-cell lymphoma , 2018, PloS one.

[3]  A. Ferrando,et al.  RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. , 2018, Cancer cell.

[4]  P. Gaulard,et al.  Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma , 2017, Leukemia.

[5]  A. Verma,et al.  Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells , 2017, Blood Cancer Journal.

[6]  P. Gaulard,et al.  Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin , 2017, Haematologica.

[7]  I. Lossos,et al.  Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas , 2017, Proceedings of the National Academy of Sciences.

[8]  Ryan D. Morin,et al.  Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. , 2016, Blood.

[9]  K. Ando,et al.  Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections , 2016, The American journal of surgical pathology.

[10]  P. Kim,et al.  Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma , 2016, Haematologica.

[11]  J. Maciejewski,et al.  Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features , 2016, The American journal of surgical pathology.

[12]  R. Eils,et al.  Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL‐BFM protocols , 2014, Genes, chromosomes & cancer.

[13]  Atsushi Tanaka,et al.  Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma , 2014, Nature Genetics.

[14]  Min Kyung Sung,et al.  A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma , 2014, Nature Genetics.

[15]  I. Lossos,et al.  Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas , 2014, Nature Genetics.

[16]  O. Nureki,et al.  Somatic RHOA mutation in angioimmunoblastic T cell lymphoma , 2014, Nature Genetics.

[17]  K. Ohshima,et al.  Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders. , 2012, American journal of clinical pathology.

[18]  W. Klapper,et al.  Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert’s personal archive , 2011, Histopathology.

[19]  C. Copie-Bergman,et al.  Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas , 2009, The American journal of surgical pathology.

[20]  T. Marafioti,et al.  Peripheral T‐cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T‐cell lymphoma , 2008, British journal of haematology.

[21]  N. Harris,et al.  Peripheral T-Cell Lymphoma With Follicular Involvement and a CD4+/bcl-6+ Phenotype , 2001, The American journal of surgical pathology.